Guizhou Xinbang Pharmaceutical Co., Ltd. (002390.SZ) announced a profit for its first quarter that Increased, from the same period last year
The company's earnings totaled RMB48.65 million, or RMB0.0257 per share. This compares with RMB41.24 million, or RMB0.0217 per share, last year.
The company's revenue for the period fell 12.4% to RMB1.263 billion from RMB1.441 billion last year.
Guizhou Xinbang Pharmaceutical Co., Ltd. earnings at a glance (GAAP) :
-Earnings: RMB48.65 Mln. vs. RMB41.24 Mln. last year.-EPS: RMB0.0257 vs. RMB0.0217 last year.-Revenue: RMB1.263 Bln vs. RMB1.441 Bln last year.
For comments and feedback contact: editorial@rttnews.com
June 19, 2026 16:46 ET Major central banks continued to dominate the economic news flow this week too, led by the Federal Reserve, as they announced their latest policy decisions. The Federal Reserve policy session was in focus as it was the first to be led by the new chief Kevin Warsh. In Europe, central banks of the U.K. and Switzerland announced their rate decisions. In Asia, the Bank of Japan drew attention for its policy moves, while data out of China threw some light on the state of the economy.